12
Participants
Start Date
March 1, 2025
Primary Completion Date
July 1, 2026
Study Completion Date
June 30, 2027
Trial Enrollment Diversity Dashboard Behavioral
A data management and classification algorithm tool that provides personalized enrollment diversity performance data for clinician review and which aims to overcome race-ethnic disparities in Leukemia clinical trial participation. Data inputs and the Dashboard are within existing HIPAA-complaint electronic health records systems used at Dana-Farber Cancer Institute, and utilization data metrics are collected through the Tableau software supporting the intervention.
Dana-Farber Cancer Institute, Boston
National Cancer Institute (NCI)
NIH
American Society of Clinical Oncology
OTHER
Dana-Farber Cancer Institute
OTHER